A phase II, multicentre, open label, prospective, interventional study to evaluate the sperm DNA fragmentation in idiopathic male infertility before and after treatment with Gonal-f PEN 900 IU.
Phase of Trial: Phase II
Latest Information Update: 27 Dec 2012
At a glance
- Drugs Follitropin alfa (Primary)
- Indications Asthenozoospermia; Azoospermia; Teratospermia
- Focus Pharmacodynamics
- 27 Dec 2012 Actual initiation date 14 Apr 2011 added as reported by EudraCT.
- 22 Mar 2012 New trial record